MedPath

ß-Hydroxy-ß-Methylbutrate (HMB) supplementation and functiOnal OutcomeS in multi-Trauma patients (BOOST TRIAL)

Not Applicable
Completed
Conditions
Multi-trauma
Critical Illness
Injuries and Accidents - Other injuries and accidents
Registration Number
ACTRN12620001305910
Lead Sponsor
The Royal Melbourne Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
51
Inclusion Criteria

a.Adults, 18 years of age and older
b.Completed two full calendar days in ICU
c.The predominant reason for ICU admission was a traumatic injury
d.Allowed enteral/ oral nutrition at the time of randomization

Inclusion criteria for the muscle biopsy sub group as above.

Exclusion Criteria

a. Death during ICU admission deemed to be inevitable
b. Bilateral above knee amputation
c. Patients assessed as requiring completely or predominantly parenteral nutrition
d. Pregnancy
e. Primary neuromuscular pathology present or strongly suspected this admission episode
f. Presumed transection of the spinal cord at any level
g. Medical decision treatment maker, participant or medical practitioner declined consent
h. Limited research availability over enrolment timeframe
I. Enrollment conflict with other research studies
j. Unlikely to be able to participate in long term follow up measures
k. Unable to obtain consent within 7 days from initial traumatic injury

Additional exclusion criteria for the muscle biopsy sub-group:
g.Not mechanically ventilated at the time of enrollment or predicted to be extubated within 48 hours of enrollment.
h.Present or strongly suspected disseminated cancer of any kind
i.Bleeding diathesis (corrected INR > 1.5 and/or APTT > 50 sec), or receiving any anticoagulant medication beyond that required for venous thromboembolism prophylaxis, or any antiplatelet drug other than low dose aspirin

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.